The Department of Veterans Affairs (VA) is conducting a sources sought notice for the acquisition of Edwards Sapien 3 Ultra Resilia Transcatheter Heart Valves through Network Contracting Office (NCO) 17. This notice indicates an intent to award a sole source contract to Edwards Lifesciences LLC if there are no other viable responses. Interested contractors are invited to submit capability statements to demonstrate their qualifications for the procurement. The submission deadline for responses is 7:00 AM Central Time on November 22, 2024. Compliance with the System for Award Management (SAM) registration and OEM authorization is mandatory for prospective suppliers. This sources sought notice aims to gather information for planning and does not constitute a formal solicitation; therefore, any expenses incurred by responders will not be covered by the VA. All participation must be in writing, and submitted documents will not be returned. This overview underscores the VA's focus on ensuring a reliable sourcing process while evaluating potential suppliers for critical medical devices.
The VA North Texas Healthcare System aims to procure Edwards SAPIEN 3 Ultra RESILIA transcatheter heart valves on a consignment basis, covering an initial contract period of December 15, 2024, to December 14, 2025, with four optional one-year renewals through 2029. The scope includes maintaining an inventory of various valve sizes as determined by attending physicians to meet patient needs. The contractor will supply and manage the consignment inventory, ensuring that replacement items are delivered within 48 hours, and will remain responsible for the ownership of unutilized products until used.
Periodic reviews of inventory levels will be conducted, with any needed adjustments made in consultation with the Contracting Officer Representative (COR). The contractor must provide on-site training and monthly reports on the consignment inventory. Additionally, the contractor is required to notify the VA of any recalls or defective products and arrange for replacements at no cost to the government. This comprehensive approach aims to ensure immediate availability of necessary medical supplies while adhering to regulatory compliance and optimized patient care. The emphasis on state-of-the-art technology aligns with advancing healthcare standards.